Story
Crypto-Linked Stocks Rally as Bitcoin Surges Past $85,000
Summary
Shares of companies with exposure to the cryptocurrency market, including MicroStrategy and Coinbase, gained on Monday after Bitcoin's price climbed more than 5% to break the $85,000 threshold.
Shares of cryptocurrency-related companies rallied on Monday as Bitcoin surged past the $85,000 level, fueling broad optimism across the digital asset market.
Digital Asset Surge
The world's largest cryptocurrency by market capitalization, Bitcoin, climbed more than 5% during the session to trade above $85,000, according to market data. The positive sentiment extended to other major digital assets, with Ethereum rising over 3% to reach $2,722.
This upward momentum in the leading cryptocurrencies provided a significant tailwind for publicly traded companies with business models tied to the crypto ecosystem, from corporate holders to trading platforms and mining operations.
AdKey Stock Movers
Several U.S.-listed stocks with exposure to digital assets saw notable gains in response to the market upswing. According to a report from Zhitong Finance, the following companies were among the top performers as of Monday's trading session:
- MicroStrategy (MSTR), a major corporate holder of Bitcoin, saw its shares jump by more than 7.5%.
- Coinbase (COIN), a leading cryptocurrency exchange, gained over 5%.
- Bitmine Immersion Technologies (BMNR) rose over 5.5%.
- SharpLink (SBET) advanced more than 5%.
- Circle (CRCL) shares were up by more than 3.7%.
- Robinhood (HOOD) shares increased by nearly 2%.
Read next
More on Stocks
Lumentum Stock Jumps on AI Optical Interconnect Demo with Qualcomm, Corning
Lumentum shares rose after the company, alongside partners Qualcomm and Corning, demonstrated a new high-density optical interconnect system designed for next-generation AI data centers.
Geek+ Repurchases 884,000 Shares for HK$7.23 Million
Logistics robotics firm Geek+ (2590.HK) announced it conducted a share buyback on September 21, 2026, purchasing 884,000 shares for a total consideration of HK$7.2314 million.
Xinhua United Investment Proposes 20-for-1 Share Consolidation
Xinhua United Investment's board has proposed a reverse stock split to consolidate every 20 existing shares into one new share, aiming to adjust its capital structure.
Laekna's Cancer Drug Opatisumimab Earns Late-Breaking Abstract Status at ESMO Congress
Laekna announced its pivotal Phase IIb study for the bispecific antibody opatisumimab in late-stage neuroendocrine carcinoma has been selected for a Late-Breaking Abstract oral presentation at the European Society for Medical Oncology Congress. The company will also present findings from two other studies in proffered oral sessions.